All Community pharmacist articles
-
PHE/DH/DWP guidelinePHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
Information
COVID-19 hub for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
NHS guideline
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
-
News
What’s new in Guidelines for Pharmacy volume 7?
Sophie Hatton reveals the highlights of the April 2021 issue of the Guidelines for Pharmacy handbook, including new and updated COVID-19 guideline summaries
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
News
Shining a spotlight on emollient fire risks
Janice Perkins offers guidance on community pharmacy’s role in raising awareness of the fire risks associated with the use of emollients
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
NICE guideline
NICE COVID-19 management
Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings
-
News
New advice on AstraZeneca COVID-19 vaccine issued following rare blood clot link
New advice has been issued by the MRHA and JCVI on the link between the COVID-19 AstraZeneca vaccine and thrombosis and thrombocytopenia
-
Independent professional body guideline
AWMSG prescribing guide
Guidance on solving prescribing dilemmas, including (but not limited to) clinical responsibility, prescribing duration, and complementary therapies
-
News
NICE publishes new guideline on chronic pain
The new guidance, entitled Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain, was developed in partnership with the Royal College of Physicians.
-
News
Office for Health Promotion established to improve public health
New Office for Health Promotion will focus on prevention of poor health and improving health outcomes
-
Concise consultation card
RELIEF AND MANAGEMENT OF DRY SKIN CONDITIONS
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-35428 March 2021 -
NICE guideline
NICE CKS on infective conjunctivitis
A summary of guidance to assist community pharmacy teams with the diagnosis and management of infective conjunctivitis
-
News
NICE publishes rapid guideline on managing COVID-19
NICE has published a new rapid guideline on the management of COVID-19, including recommendations for assessment, management, therapeutics and acute complications
-
PHE/DH/DWP guideline
PHE oral health in children guidance
A summary of guidance to assist community pharmacy teams to promote the benefits of good oral health for children
-
Supplement
Supporting patients with joint pain in community pharmacy
This content is intended for UK healthcare professionals only.
PM-UK-VOLT-20-00192 Date of preparation: January 2021 -
Concise consultation card
APPROPRIATE FEVER RELIEF FOR CHILDREN
This concise consultation card was developed by Guidelines for Pharmacy in partnership with RB UK.
Essential information and adverse reporting details are included.
RB-M-30635 February 2021
